Frontiers | Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

<sec><title>Background</title><p>The coronavirus disease 2019 (COVID-19) pandemic has created one of the largest global health crises in almost a century. Al...